DEF 14AThe Ballot
Spyre Therapeutics, Inc. files DEF 14A
Filed Apr 21, 2022 · 4y ago · Accession 0001564590-22-015010
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Spyre Therapeutics, Inc.
- Ticker
- SYRE
- CIK
- 1636282
- Form type
- DEF 14A
- Filing date
- Apr 21, 2022
- Report date
- Jun 7, 2022
- Document
- agle-def14a_20220421.htm
- Size
- 1.9 MB